US Stock MarketDetailed Quotes

10x Genomics (TXG)

Watchlist
  • 21.470
  • +0.270+1.27%
Trading May 18 12:43 ET
2.73BMarket Cap-126.29P/E (TTM)

10x Genomics (TXG) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-23.96%26.12M
1,941.57%136.05M
704.28%40.78M
99.69%43.21M
136.23%17.71M
318.45%34.35M
143.85%6.66M
-126.20%-6.75M
185.52%21.64M
165.04%7.5M
Net income from continuing operations
60.80%-13.47M
76.16%-43.54M
66.85%-16.25M
23.16%-27.47M
191.14%34.54M
42.69%-34.36M
28.41%-182.63M
-0.16%-49.03M
61.55%-35.75M
39.28%-37.9M
Operating gains losses
----
----
----
----
----
----
-99.83%3K
--0
--2K
----
Depreciation and amortization
21.36%11.91M
0.25%43.82M
14.54%12.1M
13.96%12.25M
-11.46%9.65M
-14.62%9.81M
0.20%43.71M
-9.76%10.56M
-5.87%10.75M
-8.23%10.9M
Other non cash items
56.52%-250K
-166.16%-346K
-152.08%-121K
1,030.65%701K
-640.00%-351K
-229.50%-575K
22.48%523K
---48K
--62K
--65K
Change In working capital
-81.30%5.29M
1,888.76%24.94M
1,450.15%18.58M
144.54%31.77M
-1,220.76%-53.69M
549.10%28.28M
-92.77%1.25M
-108.06%-1.38M
-19.65%12.99M
59.08%-4.07M
-Change in receivables
-26.09%26.11M
-76.10%6.44M
422.70%14.1M
194.22%22.91M
-329,560.00%-65.89M
50.22%35.33M
353.94%26.95M
60.18%-4.37M
148.16%7.79M
100.21%20K
-Change in inventory
-66.47%2.7M
385.91%27.95M
-41.97%5.58M
270.98%7.29M
235.19%7.03M
181.09%8.06M
-224.22%-9.78M
26.33%9.62M
-265.97%-4.26M
-179.11%-5.2M
-Change in prepaid assets
135.17%1.95M
-23.25%-2.34M
-14.94%-2.99M
-7.31%1.38M
288.40%4.79M
-172.55%-5.53M
21.74%-1.9M
-313.39%-2.6M
197.96%1.49M
-42.11%1.23M
-Change in payables and accrued expense
-210.38%-1.97M
54.76%-7.28M
92.98%-632K
-982.81%-7.24M
-171.00%-1.19M
122.02%1.78M
-172.20%-16.09M
-156.45%-9M
-114.76%-669K
-39.31%1.67M
-Change in other current assets
-87.81%282K
163.56%689K
-309.01%-1.6M
-152.65%-149K
105.32%125K
971.30%2.31M
-59.88%-1.08M
297.42%766K
-98.41%283K
69.10%-2.35M
-Change in other current liabilities
-27.87%-2.9M
23.86%-8.91M
-2.08%-2.65M
39.38%-2.32M
34.90%-1.68M
16.26%-2.27M
-58.49%-11.71M
-19.29%-2.59M
-315.17%-3.83M
-14.61%-2.57M
-Change in other working capital
-83.18%-20.88M
-43.53%8.39M
-0.57%6.76M
-18.73%9.91M
-0.29%3.12M
-57.00%-11.4M
79.18%14.86M
16.63%6.8M
23.23%12.2M
-52.90%3.13M
Cash from discontinued investing activities
Operating cash flow
-23.96%26.12M
1,941.57%136.05M
704.28%40.78M
99.69%43.21M
136.23%17.71M
318.45%34.35M
143.85%6.66M
-126.20%-6.75M
185.52%21.64M
165.04%7.5M
Investing cash flow
Cash flow from continuing investing activities
30.74%-1.31M
58.82%-13.44M
96.50%-1.81M
-143.26%-8.8M
-107.86%-939K
-117.80%-1.89M
-124.44%-32.63M
-493.89%-51.59M
-173.84%-3.62M
367.75%11.95M
Net PPE purchase and sale
15.64%-1.6M
52.11%-5.94M
34.57%-1.78M
82.33%-687K
45.17%-1.58M
34.95%-1.89M
74.50%-12.39M
21.28%-2.72M
74.47%-3.89M
88.65%-2.88M
Net intangibles purchase and sale
----
--0
--0
--0
----
----
-8.34%-1M
--0
--0
---1M
Net business purchase and sale
----
----
----
----
----
----
--0
----
----
----
Net investment purchase and sale
--286K
109.17%1.77M
101.28%624K
85.24%502K
-95.96%639K
--0
-110.51%-19.24M
-395.36%-48.88M
-98.67%271K
-24.26%15.83M
Net other investing changes
----
---9.27M
---652K
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
30.74%-1.31M
58.82%-13.44M
96.50%-1.81M
-143.26%-8.8M
-107.86%-939K
-117.80%-1.89M
-124.44%-32.63M
-493.89%-51.59M
-173.84%-3.62M
367.75%11.95M
Financing cash flow
Cash flow from continuing financing activities
-2,094.55%-8.42M
-37.67%6.8M
-50.37%2.24M
295.51%617K
-23.48%3.52M
-74.24%422K
-20.16%10.91M
-19.53%4.52M
-96.43%156K
-35.13%4.6M
Proceeds from stock option exercised by employees
-35.31%273K
-37.67%6.8M
-50.37%2.24M
295.51%617K
-23.48%3.52M
-74.24%422K
-43.98%10.91M
-19.53%4.52M
-96.43%156K
-35.13%4.6M
Net other financing activities
---8.69M
----
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-2,094.55%-8.42M
-37.67%6.8M
-50.37%2.24M
295.51%617K
-23.48%3.52M
-74.24%422K
-20.16%10.91M
-19.53%4.52M
-96.43%156K
-35.13%4.6M
Net cash flow
Beginning cash position
37.75%473.97M
-4.24%344.07M
8.68%432.71M
4.71%397.71M
5.98%377.06M
-4.24%344.07M
58.03%359.28M
26.50%398.16M
14.80%379.82M
4.70%355.78M
Current changes in cash
-50.15%16.39M
959.73%129.42M
176.57%41.21M
92.69%35.03M
-15.62%20.29M
1,051.66%32.88M
-111.41%-15.05M
-221.03%-53.82M
213.41%18.18M
370.42%24.05M
Effect of exchange rate changes
-164.04%-73K
395.12%484K
115.99%43K
-121.15%-33K
12,100.00%360K
337.50%114K
-396.97%-164K
-449.35%-269K
283.53%156K
93.88%-3K
End cash Position
30.03%490.29M
37.75%473.97M
37.75%473.97M
8.68%432.71M
4.71%397.71M
5.98%377.06M
-4.24%344.07M
-4.24%344.07M
26.50%398.16M
14.80%379.82M
Free cash flow
-24.45%24.52M
2,033.65%130.12M
512.09%39M
139.56%42.53M
345.83%16.13M
274.18%32.46M
89.60%-6.73M
-142.42%-9.46M
143.57%17.75M
109.81%3.62M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -23.96%26.12M1,941.57%136.05M704.28%40.78M99.69%43.21M136.23%17.71M318.45%34.35M143.85%6.66M-126.20%-6.75M185.52%21.64M165.04%7.5M
Net income from continuing operations 60.80%-13.47M76.16%-43.54M66.85%-16.25M23.16%-27.47M191.14%34.54M42.69%-34.36M28.41%-182.63M-0.16%-49.03M61.55%-35.75M39.28%-37.9M
Operating gains losses -------------------------99.83%3K--0--2K----
Depreciation and amortization 21.36%11.91M0.25%43.82M14.54%12.1M13.96%12.25M-11.46%9.65M-14.62%9.81M0.20%43.71M-9.76%10.56M-5.87%10.75M-8.23%10.9M
Other non cash items 56.52%-250K-166.16%-346K-152.08%-121K1,030.65%701K-640.00%-351K-229.50%-575K22.48%523K---48K--62K--65K
Change In working capital -81.30%5.29M1,888.76%24.94M1,450.15%18.58M144.54%31.77M-1,220.76%-53.69M549.10%28.28M-92.77%1.25M-108.06%-1.38M-19.65%12.99M59.08%-4.07M
-Change in receivables -26.09%26.11M-76.10%6.44M422.70%14.1M194.22%22.91M-329,560.00%-65.89M50.22%35.33M353.94%26.95M60.18%-4.37M148.16%7.79M100.21%20K
-Change in inventory -66.47%2.7M385.91%27.95M-41.97%5.58M270.98%7.29M235.19%7.03M181.09%8.06M-224.22%-9.78M26.33%9.62M-265.97%-4.26M-179.11%-5.2M
-Change in prepaid assets 135.17%1.95M-23.25%-2.34M-14.94%-2.99M-7.31%1.38M288.40%4.79M-172.55%-5.53M21.74%-1.9M-313.39%-2.6M197.96%1.49M-42.11%1.23M
-Change in payables and accrued expense -210.38%-1.97M54.76%-7.28M92.98%-632K-982.81%-7.24M-171.00%-1.19M122.02%1.78M-172.20%-16.09M-156.45%-9M-114.76%-669K-39.31%1.67M
-Change in other current assets -87.81%282K163.56%689K-309.01%-1.6M-152.65%-149K105.32%125K971.30%2.31M-59.88%-1.08M297.42%766K-98.41%283K69.10%-2.35M
-Change in other current liabilities -27.87%-2.9M23.86%-8.91M-2.08%-2.65M39.38%-2.32M34.90%-1.68M16.26%-2.27M-58.49%-11.71M-19.29%-2.59M-315.17%-3.83M-14.61%-2.57M
-Change in other working capital -83.18%-20.88M-43.53%8.39M-0.57%6.76M-18.73%9.91M-0.29%3.12M-57.00%-11.4M79.18%14.86M16.63%6.8M23.23%12.2M-52.90%3.13M
Cash from discontinued investing activities
Operating cash flow -23.96%26.12M1,941.57%136.05M704.28%40.78M99.69%43.21M136.23%17.71M318.45%34.35M143.85%6.66M-126.20%-6.75M185.52%21.64M165.04%7.5M
Investing cash flow
Cash flow from continuing investing activities 30.74%-1.31M58.82%-13.44M96.50%-1.81M-143.26%-8.8M-107.86%-939K-117.80%-1.89M-124.44%-32.63M-493.89%-51.59M-173.84%-3.62M367.75%11.95M
Net PPE purchase and sale 15.64%-1.6M52.11%-5.94M34.57%-1.78M82.33%-687K45.17%-1.58M34.95%-1.89M74.50%-12.39M21.28%-2.72M74.47%-3.89M88.65%-2.88M
Net intangibles purchase and sale ------0--0--0---------8.34%-1M--0--0---1M
Net business purchase and sale --------------------------0------------
Net investment purchase and sale --286K109.17%1.77M101.28%624K85.24%502K-95.96%639K--0-110.51%-19.24M-395.36%-48.88M-98.67%271K-24.26%15.83M
Net other investing changes -------9.27M---652K----------------------------
Cash from discontinued investing activities
Investing cash flow 30.74%-1.31M58.82%-13.44M96.50%-1.81M-143.26%-8.8M-107.86%-939K-117.80%-1.89M-124.44%-32.63M-493.89%-51.59M-173.84%-3.62M367.75%11.95M
Financing cash flow
Cash flow from continuing financing activities -2,094.55%-8.42M-37.67%6.8M-50.37%2.24M295.51%617K-23.48%3.52M-74.24%422K-20.16%10.91M-19.53%4.52M-96.43%156K-35.13%4.6M
Proceeds from stock option exercised by employees -35.31%273K-37.67%6.8M-50.37%2.24M295.51%617K-23.48%3.52M-74.24%422K-43.98%10.91M-19.53%4.52M-96.43%156K-35.13%4.6M
Net other financing activities ---8.69M------------------------------------
Cash from discontinued financing activities
Financing cash flow -2,094.55%-8.42M-37.67%6.8M-50.37%2.24M295.51%617K-23.48%3.52M-74.24%422K-20.16%10.91M-19.53%4.52M-96.43%156K-35.13%4.6M
Net cash flow
Beginning cash position 37.75%473.97M-4.24%344.07M8.68%432.71M4.71%397.71M5.98%377.06M-4.24%344.07M58.03%359.28M26.50%398.16M14.80%379.82M4.70%355.78M
Current changes in cash -50.15%16.39M959.73%129.42M176.57%41.21M92.69%35.03M-15.62%20.29M1,051.66%32.88M-111.41%-15.05M-221.03%-53.82M213.41%18.18M370.42%24.05M
Effect of exchange rate changes -164.04%-73K395.12%484K115.99%43K-121.15%-33K12,100.00%360K337.50%114K-396.97%-164K-449.35%-269K283.53%156K93.88%-3K
End cash Position 30.03%490.29M37.75%473.97M37.75%473.97M8.68%432.71M4.71%397.71M5.98%377.06M-4.24%344.07M-4.24%344.07M26.50%398.16M14.80%379.82M
Free cash flow -24.45%24.52M2,033.65%130.12M512.09%39M139.56%42.53M345.83%16.13M274.18%32.46M89.60%-6.73M-142.42%-9.46M143.57%17.75M109.81%3.62M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More